The Myd88L252P tumor signature also strikingly confirms that lymphoplasmacytic differentiation is at the heart of MYD88 related B-cell transformation in mice, a feature shared with WM tumors with the MYD88L265P mutation. Here, MYD88 is linked to neoplasm.